---
schema_version: "secwatch.filing_event.v1"
accession: "0001005286-24-000128"
form_type: "8-K"
ticker: "LFCR"
cik: "0001005286"
company_name: "LIFECORE BIOMEDICAL, INC. DE"
filed_at: "2024-08-29T23:59:59+00:00"
generated_at: "2026-05-31T06:55:52.364643+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lifecore appoints Ryan Lake as CFO effective Sept 3; Morberg departs Sept 2

## Summary
- John Morberg steps down as CFO effective Sept 2, 2024; Ryan Lake succeeds him on Sept 3, 2024.
- Lake receives $470K base salary, RSU for 262,500 shares, and PSU for up to 750,000 shares under Inducement Plan.
- Lake previously served as CFO of Societal CDMO, leading its sale to CoreRx in April 2024.
- Morberg's separation treated as termination without Cause after a Change in Control under his employment agreement.

## SEC filing metadata
- accession: 0001005286-24-000128
- form_type: 8-K
- ticker: LFCR
- cik: 0001005286
- company_name: LIFECORE BIOMEDICAL, INC. DE
- filed_at: 2024-08-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.02, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/0001005286-24-000128-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/lndc-20240828.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001005286-24-000128
- JSON: https://secwatch.observer/filing/0001005286-24-000128.json
- Plain text: https://secwatch.observer/filing/0001005286-24-000128.txt

## Key facts
- Executive change
  Ryan D. Lake was appointed as Chief Financial Officer and Secretary at LIFECORE BIOMEDICAL, INC. DE.
  - Action: appointed
  - Role: Chief Financial Officer and Secretary
  source text: On August 28, 2024, the Company appointed Ryan D. Lake as the Company’s Chief Financial Officer and Secretary, effective September 3, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/0001005286-24-000128-index.htm
- Executive change
  John D. Morberg departed as Chief Financial Officer and Secretary at LIFECORE BIOMEDICAL, INC. DE.
  - Action: employment will end
  - Role: Chief Financial Officer and Secretary
  source text: Mr. Morberg's separation will be treated as a termination by the Company without Cause subsequent to a Change in Control under that certain Executive Employment Agreement (the "Morberg Employment Agreement"), dated January 19, 2021, between the Company and Mr. Morberg
  evidence_url: https://www.sec.gov/Archives/edgar/data/1005286/000100528624000128/0001005286-24-000128-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.